Markets:

Overview

News

Currencies

International

Treasuries

Myovant Sciences Ltd. Common Shares (NY:MYOV)

N/A UNCHANGED

Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Myovant Sciences Ltd. Common Shares

< Previous 1 2 3 4 Next >

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2022

The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a...

Via Benzinga

SVB Leerink Maintains Market Perform Rating for Myovant Sciences, Lowers Price Target To $12 ↗

April 13, 2022

SVB Leerink has decided to maintain its Market Perform rating of Myovant Sciences (NYSE:MYOV) and lower its price target from $19.00 to $12.00. Shares of Myovant Sciences are trading up 8.08% over the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 12, 2022

Gainers

Via Benzinga

Dow, Nasdaq Up Triple Digits as Wall Street Bets on Inflation's Top ↗

April 12, 2022

Despite a slightly hotter-than-expected March consumer price index (CPI) reading earlier today, stocks are moving higher, as Wall Street bets on inflation's peak.

Via Talk Markets

Earnings Scheduled For October 26, 2021 ↗

October 26, 2021

Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Myovant Sciences Collapses As FDA Holdup Snags Its Blockbuster Potential ↗

April 12, 2022

The Pfizer-partnered endometriosis drug is facing additional FDA scrutiny.

Via Investor's Business Daily

What's Going On With Myovant Sciences Stock Today? ↗

April 12, 2022

Myovant Sciences Ltd (NYSE: MYOV) shares are trading significantly lower Tuesday after the company and Pfizer Inc (NYSE: PFE) announced an update on the Supplemental New...

Via Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗

April 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Urovant Reports Publication of New Efficacy, Safety Data On Gemtesa For Overactive Bladder ↗

March 22, 2022

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd, announced the

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 16, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 25, 2022

Gainers Surgalign Holdings (NASDAQ:SRGA) ...

Via Benzinga

Bear Market Bets In Biotech ↗

February 07, 2022

Taken together, the SPDR S&P Biotech ETF easily broke below the long-term 200-week support for the first time since the pandemic originally hit the markets in March of 2020.

Via Talk Markets

Myovant Sciences's Return on Invested Capital Insights ↗

January 27, 2022

Myovant Sciences (NYSE:MYOV) brought in sales totaling $54.44 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 193.85%, resulting in a...

Via Benzinga

Myovant Sciences: Q3 Earnings Insights ↗

January 26, 2022

Myovant Sciences (NYSE:MYOV) reported its Q3 earnings results on Wednesday, January 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 03, 2021

Gainers Lixte Biotech Holdings (NASDAQ:LIXT

Via Benzinga

Earnings Scheduled For January 26, 2022 ↗

January 26, 2022

Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to...

Via Benzinga

Myovant Sciences Ltd. (MYOV) Q2 2021 Earnings Call Transcript ↗

October 26, 2021

MYOV earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat? ↗

October 26, 2021

Tucked in its Q2 earnings release, Myovant Sciences Ltd (NYSE: MYOV) said that Pfizer Inc (NYSE: PFE) has notified its option decision for international...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 26, 2021

Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million,...

Via Benzinga

Myovant Sciences Earnings Perspective: Return On Capital Employed ↗

October 26, 2021

According to Benzinga Pro data, during Q2, Myovant Sciences (NYSE:MYOV) posted sales of $77.90 million. Earnings were up 67.99%, but Myovant Sciences still reported an overall...

Via Benzinga

The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children ↗

October 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 26, 2021

Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion....

Via Benzinga

Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More ↗

September 25, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The week's most notable insider buys were at two...

Via Benzinga

3 Stocks Insiders Are Buying ↗

September 13, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

3 Stocks Insiders Are Buying ↗

September 07, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

The Past Week's Notable Insider Buys: Cano Health, Cricut, GoodRx, SelectQuote And More ↗

September 04, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were making return trips to the buy window...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

3 Stocks Insiders Are Buying ↗

August 27, 2021

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Myovant Sciences Ltd. Common Shares (NY:MYOV)

Headline News about Myovant Sciences Ltd. Common Shares

Starting at $3.75/week.

Subscribe Today